JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RBOT
5251
DELISTED
Vicarious Surgical
RBOT
| $105K | ﹤0.01% |
691
-264
| -28% | -$49.1K |
|
|
LENZ
5252
LENZ Therapeutics
LENZ
$149M
| $105K | ﹤0.01% |
2,932
+1,311
| +81% | +$82K |
|
5253
Aveanna Healthcare
AVAH
$2.68B
| $104K | ﹤0.01% |
30,481
-19,945
| -40% | -$108K |
|
5254
Claros Mortgage Trust
CMTG
$257M
| $104K | ﹤0.01% |
+6,075
| New | +$106K |
|
5255
Citius Pharmaceuticals
CTXR
$20.7M
| $104K | ﹤0.01% |
2,328
+581
| +33% | +$22.9K |
|
|
IMA
5256
ImageneBio Inc
IMA
$66.3M
| $104K | ﹤0.01% |
1,431
+290
| +25% | +$30.8K |
|
|
KORE
5257
DELISTED
KORE Group Holdings
KORE
| $104K | ﹤0.01% |
3,483
+761
| +28% | +$21.4K |
|
|
WEBR
5258
DELISTED
Weber Inc.
WEBR
| $104K | ﹤0.01% |
10,544
-8,644
| -45% | -$93.1K |
|
5259
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
| $103K | ﹤0.01% |
+1,339
| New | +$88.5K |
|
5260
CALL
Li Auto
LI
$12B
| $103K | ﹤0.01% |
4,000
| – | – |
|
5261
NewtekOne
NEWT
$376M
| $103K | ﹤0.01% |
3,865
-2,260
| -37% | -$60.9K |
|
5262
TORM
TRMD
$3.08B
| $103K | ﹤0.01% |
+11,627
| New | +$91.7K |
|
|
VTYX
5263
DELISTED
Ventyx Biosciences
VTYX
| $103K | ﹤0.01% |
7,593
-55,717
| -88% | -$744K |
|
5264
Zevia
ZVIA
$102M
| $103K | ﹤0.01% |
22,531
-7,202
| -24% | -$50.1K |
|
|
HYFT
5265
MindWalk Holdings
HYFT
$66.3M
| $102K | ﹤0.01% |
19,904
-40,217
| -67% | -$207K |
|
|
KG
5266
Kestrel Group
KG
$61.7M
| $102K | ﹤0.01% |
2,096
-2,959
| -59% | -$156K |
|
5267
RxSight
RXST
$287M
| $102K | ﹤0.01% |
8,227
+2,820
| +52% | +$33.9K |
|
|
VIRX
5268
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $102K | ﹤0.01% |
21,441
+4,210
| +24% | +$12.7K |
|
|
CPARW
5269
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
| – | – |
0
| – | – |
|
5270
Aldeyra Therapeutics
ALDX
$94.1M
| $101K | ﹤0.01% |
22,835
+4,012
| +21% | +$16K |
|
5271
Ceco Environmental
CECO
$4.66B
| $101K | ﹤0.01% |
18,423
-24,882
| -57% | -$145K |
|
5272
ORIX
IX
$43.6B
| $101K | ﹤0.01% |
5,090
-195
| -4% | -$3.98K |
|
5273
State Street SPDR Dow Jones International Real Estate ETF
RWX
$266M
| $101K | ﹤0.01% |
2,960
-1
| -0% | -$34 |
|
5274
VirTra
VTSI
$36.5M
| $101K | ﹤0.01% |
16,618
-31,766
| -66% | -$196K |
|
5275
iShares US Industrials ETF
IYJ
$1.97B
| $100K | ﹤0.01% |
945
-8,987
| -90% | -$948K |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.